Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:scientist
biologist |
| gptkbp:almaMater |
gptkb:University_of_Leeds
|
| gptkbp:awardReceived |
gptkb:Japan_Prize
gptkb:Lasker-DeBakey_Clinical_Medical_Research_Award |
| gptkbp:birthPlace |
gptkb:United_Kingdom
|
| gptkbp:birthYear |
1957
|
| gptkbp:employer |
gptkb:Ciba-Geigy
gptkb:Novartis |
| gptkbp:fieldOfWork |
gptkb:pharmacy
oncology |
| https://www.w3.org/2000/01/rdf-schema#label |
Nicholas Lydon
|
| gptkbp:knownFor |
cancer research
development of imatinib |
| gptkbp:nationality |
British
|
| gptkbp:notableWork |
gptkb:imatinib_(Gleevec)
|
| gptkbp:occupation |
biologist
chemist |
| gptkbp:bfsParent |
gptkb:Lasker_Award
|
| gptkbp:bfsLayer |
4
|